1. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations

   • Federico Verde
   • Ilaria Milone
   • Vincenzo Silani

   Original Communication 04 July 2022 Pages: 5691 - 5701

   

2. Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors

   • Alicia Gonzalez-Martinez
   • Ángel Luis Guerrero-Peral
   • David García-Azorín

   Original Communication Open access 12 July 2022 Pages: 5702 - 5709

   

3. Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry

   • Felix Kohle
   • Marie Madlener
   • Michael Peter Malter

   Original Communication Open access 08 July 2022 Pages: 5710 - 5719

   

4. Anti-LGI1 encephalitis following COVID-19 vaccination: a case series

   • Gian Maria Asioli
   • Lorenzo Muccioli
   • Pietro Cortelli

   Letter to the Editors 25 June 2022 Pages: 5720 - 5723

   

5. Age-dependent perturbation of the perceptual and postural vertical by visual roll vection and susceptibility to motion sickness in children

   • Lutz Schnabel
   • Max Wuehr
   • Doreen Huppert

   Original Communication Open access 25 February 2022 Pages: 5724 - 5730

   

6. Combining vestibular rehabilitation with noisy galvanic vestibular stimulation for treatment of bilateral vestibulopathy

   • Josefine Eder
   • Silvy Kellerer
   • Klaus Jahn

   Original Communication Open access 25 February 2022 Pages: 5731 - 5737

   

7. Different strategies in pointing tasks and their impact on clinical bedside tests of spatial orientation

   • J. Gerb
   • T. Brandt
   • M. Dieterich

   Original Communication Open access 08 March 2022 Pages: 5738 - 5745

   

8. Impact on daily mobility and risk of falling in bilateral vestibulopathy

   • M. Wuehr
   • J. Decker
   • R. Schniepp

   Original Communication Open access 14 March 2022 Pages: 5746 - 5754

   

9. Reported thresholds of self-motion perception are influenced by testing paradigm

   • M. Pleshkov
   • N. Rondas
   • R. van de Berg

   Original Communication Open access 16 March 2022 Pages: 5755 - 5761

   

10. Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease

    • Chukwunonso K. Nwabufo
    • Omozojie P. Aigbogun

    Review 13 July 2022 Pages: 5762 - 5786

    

11. Sarcopenia and nervous system disorders

    • Jie Yang
    • Feifei Jiang
    • Zhizhi Chen

    Review 13 July 2022 Pages: 5787 - 5797

12. Influence of heavy metals in Parkinson’s disease: an overview

    • Balachandar Vellingiri
    • Atchaya Suriyanarayanan
    • Abilash Valsala Gopalakrishnan

    Review 28 July 2022 Pages: 5798 - 5811

    

13. Movement disorders of the mouth: a review of the common phenomenologies

    • C. M. Ghadery
    • L. V. Kalia
    • B. S. Connolly

    Review 29 July 2022 Pages: 5812 - 5830

14. Evidence for cognitive impairment in patients with vestibular disorders

    • Divya A. Chari
    • Amsal Madhani
    • Richard F. Lewis

    Review 05 August 2022 Pages: 5831 - 5842

    

15. Dance classes improve self-esteem and quality of life in persons with Parkinson’s disease

    • Wya Feenstra
    • Jorik Nonnekes
    • Bas R. Bloem

    Original Communication 28 June 2022 Pages: 5843 - 5847

16. Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience

    • Claudia Altamura
    • Nicoletta Brunelli
    • For the GARLIT Study Group

    Original Communication 28 June 2022 Pages: 5848 - 5857

    

17. Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial

    • Silvia Bonanno
    • Riccardo Giossi
    • Lorenzo Maggi

    Original Communication 28 June 2022 Pages: 5858 - 5867

18. Clinico-biological markers for the prognosis of status epilepticus in adults

    • Aurélie Hanin
    • Sophie Demeret
    • Vincent Navarro

    Original Communication 29 June 2022 Pages: 5868 - 5882

    

19. Acute serum free thiols: a potentially modifiable biomarker of oxidative stress following traumatic brain injury

    • Koen Visser
    • Harm Jan van der Horn
    • Joukje van der Naalt

    Original Communication Open access 01 July 2022 Pages: 5883 - 5892

    

20. Guillain–Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity

    • Xiaoping Tan
    • Yang Liu
    • Yang Guo

    Original Communication 03 July 2022 Pages: 5893 - 5900

    

21. Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy

    • Karine Eid
    • Øivind Torkildsen
    • Marte-Helene Bjørk

    Original Communication Open access 03 July 2022 Pages: 5901 - 5909

    

22. Quality of life and mental health in the locked-in-state—differences between patients with amyotrophic lateral sclerosis and their next of kin

    • Elisa Aust
    • Katharina Linse
    • Andreas Hermann

    Original Communication Open access 06 July 2022 Pages: 5910 - 5925

    

23. Structural connectivity alterations in the motor network of patients with scans without evidence of dopaminergic deficit (SWEDD)

    • Maria Eugenia Caligiuri
    • Andrea Quattrone
    • Aldo Quattrone

    Original Communication 06 July 2022 Pages: 5926 - 5933

    

24. Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?

    • Patrick Stancu
    • Pia De Stefano
    • Margitta Seeck

    Original Communication Open access 07 July 2022 Pages: 5934 - 5939

    

25. Improvement in motor symptoms, physical fatigue, and self-rated change perception in functional motor disorders: a prospective cohort study of a 12-week telemedicine program

    • Marialuisa Gandolfi
    • Angela Sandri
    • Michele Tinazzi

    Original Communication Open access 09 July 2022 Pages: 5940 - 5953

    

26. Limbic covariance network alterations in patients with transient global amnesia

    • Jaeho Kang
    • Dong Ah Lee
    • Kang Min Park

    Original Communication 09 July 2022 Pages: 5954 - 5962

    

27. The impact of multiple gender dimensions on health-related quality of life in persons with Parkinson’s disease: an exploratory study

    • Irene Göttgens
    • Sirwan K. L. Darweesh
    • Sabine Oertelt-Prigione

    Original Communication Open access 14 July 2022 Pages: 5963 - 5972

28. Comparison of early- and late-phase CT angiography findings in brain death

    • Ethem Murat Arsava
    • Cansu Ayvacioglu Cagan
    • Mehmet Akif Topcuoglu

    Original Communication 16 July 2022 Pages: 5973 - 5980

    

29. Attention impairment in motor functional neurological disorders: a neuropsychological study

    • Gabriela Věchetová
    • Tomáš Nikolai
    • Tereza Serranová

    Original Communication 17 July 2022 Pages: 5981 - 5990

30. The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia

    • Harald Hefter
    • Beyza Ürer
    • Sara Samadzadeh

    Original Communication Open access 17 July 2022 Pages: 5991 - 6002

    

31. Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey

    • Jochem Helleman
    • Barbara Johnson
    • Ruben P. A. van Eijk

    Original Communication Open access 18 July 2022 Pages: 6003 - 6013

    

32. Risk and cause of death in post-traumatic epilepsy: a register-based retrospective cohort study

    • Markus Karlander
    • Johan Ljungqvist
    • Johan Zelano

    Original Communication Open access 19 July 2022 Pages: 6014 - 6020

    

33. Comparison of Botulinum neurotoxin efficiency in dystonia associated with Parkinson’s disease and atypical parkinsonism: a retrospective study with a self-reported improvement scale

    • Arnaud Lapostolle
    • Marion Houot
    • Bertrand Degos

    Original Communication 19 July 2022 Pages: 6021 - 6028

    

34. Cerebellar voxel-based morphometry in essential tremor

    • Alessia Sarica
    • Andrea Quattrone
    • Aldo Quattrone

    Original Communication 19 July 2022 Pages: 6029 - 6035

    

35. Long-term vascular events after subarachnoid hemorrhage

    • Isabel Fernandez-Perez
    • Eva Giralt-Steinhauer
    • Angel Ois

    Original Communication 20 July 2022 Pages: 6036 - 6042

    

36. No exaggerated tremor severity perception in functional tremor

    • Anne-Catherine M. L. Huys
    • Patrick Haggard
    • Mark J. Edwards

    Original Communication 20 July 2022 Pages: 6043 - 6048

    

37. DNA hypermethylation of NOTCH2NLC in neuronal intranuclear inclusion disease: a case–control study

    • Yuwen Cao
    • Wotu Tian
    • Xinghua Luan

    Original Communication 20 July 2022 Pages: 6049 - 6057

    

38. Acute corticospinal tract diffusion tensor imaging predicts 6-month functional outcome after intracerebral haemorrhage

    • G. Schwarz
    • B. Kanber
    • David J. Werring

    Original Communication Open access 21 July 2022 Pages: 6058 - 6066

    

39. Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study

    • Raphael Scherbaum
    • Andreas Moewius
    • Lars Tönges

    Original Communication Open access 21 July 2022 Pages: 6067 - 6085

    

40. Prevalence of intronic repeat expansions in RFC1 in Dutch patients with CANVAS and adult-onset ataxia

    • Fatemeh Ghorbani
    • Jelkje de Boer-Bergsma
    • Dineke S. Verbeek

    Original Communication Open access 21 July 2022 Pages: 6086 - 6093

    

41. A longitudinal ¹⁸F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt–Jakob disease linked to G114V mutation

    • Min Chu
    • Zhongyun Chen
    • Liyong Wu

    Original Communication Open access 21 July 2022 Pages: 6094 - 6103

    

42. Are smartphones and machine learning enough to diagnose tremor?

    • Arjun Balachandar
    • Musleh Algarni
    • Alfonso Fasano

    Original Communication 21 July 2022 Pages: 6104 - 6115

    

43. Subthalamic deep brain stimulation for refractory Gilles de la Tourette’s syndrome: clinical outcome and functional connectivity

    • Lulin Dai
    • Wenying Xu
    • Dianyou Li

    Original Communication Open access 21 July 2022 Pages: 6116 - 6126

    

44. Correction: Subthalamic deep brain stimulation for refractory Gilles de la Tourette’s syndrome: clinical outcome and functional connectivity

    • Lulin Dai
    • Wenying Xu
    • Dianyou Li

    Correction Open access 18 August 2022 Pages: 6127 - 6128

    

45. Real-time monitoring of intravenous thrombolysis in acute ischemic stroke using rotational thromboelastometry: a feasibility pilot study

    • Alexander Tinchon
    • Elisabeth Freydl
    • Stefan Oberndorfer

    Short Commentary Open access 19 July 2022 Pages: 6129 - 6138

    

46. Motor-neuron-disease-like phenotype associated with IgLON5 disease

    • Sri Raghav Sista
    • Brian Crum
    • Divyanshu Dubey

    Short Commentary 20 July 2022 Pages: 6139 - 6144

47. Paraneoplastic neuronal intermediate filament presenting as encephalopathy and myoclonus: a case report and literature review

    • Leigh Rettenmaier
    • Lama Abdel-Wahed
    • Christopher L. Groth

    Letter to the Editors 23 May 2022 Pages: 6145 - 6147

    

48. “Ears of the lynx” sign and thin corpus callosum on MRI in heterozygous SPG11 mutation carriers

    • Tim W. Rattay
    • Ludger Schöls
    • Tobias Lindig

    Letter to the Editors 25 May 2022 Pages: 6148 - 6151

    

49. Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

    • Camilla M. M. Strano
    • Benedetta Sorrenti
    • Massimo Filippi

    Letter to the Editors 16 June 2022 Pages: 6152 - 6154

    

50. Brainstem stroke presenting with uncontrollable laughter: be alert when nobody else is laughing

    • Tarig Abkur
    • Jonathan Cleaver
    • Gopinath Ramadurai

    Letter to the Editors 19 June 2022 Pages: 6155 - 6157